Literature DB >> 11089829

Antibodies to endostatin in a multifocal glioblastoma patient.

D Ratel, V Nasser, I Dupré, A L Benabid, F Berger.   

Abstract

Endostatin, a C-terminal fragment of collagen XVIII is involved in the regulation of neovascularisation in solid tumours in mice. However, few data are available on the concentration of endostatin protein in patients with cancer. Paradoxical results obtained in this way prompted us to investigate an antibody to endostatin. We detected antibodies to endostatin in the serum and in the tumour brain tissue of a patient with a multifocal glioblastoma, and in the serum samples from two patients with aggressive tumours. These data suggest that endostatin overexpression by tumour tissue might induce a humoral immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11089829     DOI: 10.1016/S0140-6736(00)03164-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

Review 1.  Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers.

Authors:  Chiara Poluzzi; Renato V Iozzo; Liliana Schaefer
Journal:  Adv Drug Deliv Rev       Date:  2015-10-27       Impact factor: 15.470

Review 2.  Usage of cancer associated autoantibodies in the detection of disease.

Authors:  Steven P Dudas; Madhumita Chatterjee; Michael A Tainsky
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 3.  Angiogenesis factors in gliomas: a new key to tumour therapy?

Authors:  Rolf Mentlein; Janka Held-Feindt
Journal:  Naturwissenschaften       Date:  2003-07-29

Review 4.  Cellular actions and signaling by endostatin.

Authors:  Ramani Ramchandran; S Ananth Karumanchi; Jun-ichi Hanai; Seth L Alper; Vikas P Sukhatme
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2002       Impact factor: 1.807

Review 5.  Delivery of endostatin in experimental cancer therapy.

Authors:  Dag R Sorensen; Tracy-Ann Read
Journal:  Int J Exp Pathol       Date:  2002-12       Impact factor: 1.925

6.  Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome.

Authors:  T Bachelot; D Ratel; C Menetrier-Caux; D Wion; J-Y Blay; F Berger
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.